ICUconnect for Palliative Care in Older Adults
(ICUconnect 2 Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What data supports the effectiveness of the treatment ICUconnect for palliative care in older adults?
Research on integrated palliative care (IPC) suggests that it can improve the quality of care for patients and support caregivers, which may indicate potential benefits for treatments like ICUconnect. Additionally, using palliative care assessment tools has been shown to enhance communication and care planning, which could be relevant to ICUconnect's effectiveness.12345
How is the ICUconnect treatment unique for palliative care in older adults?
What is the purpose of this trial?
Millions of older adults receive care in intensive care units (ICUs) annually. However, the quality and accessibility of ICU-based palliative care is highly variable across hospitals and clinicians, due in part to specialists' limited workforce and geographic inconsistency. To address these gaps, the investigators developed an innovative mobile app-based primary palliative care intervention called ICUconnect. ICUconnect facilitates families' and patients' self-report of actual palliative care needs across all core domains of palliative care quality, provides ICU clinicians with a scalable digital infrastructure for coordinating consistent and personalized needs-targeted care, and provides a variety of informational supports relevant to each user's role. In this RCT, the investigators will test ICUconnect vs. usual care control among 350 patient-family member dyads with elevated baseline levels of unmet palliative care need in a 4-site network serving a diverse population (Duke, Medical University of South Carolina, University of Alabama at Birmingham, Columbia).The specific aims are to: (1) Test the efficacy of ICUconnect vs. usual care control in improving palliative care needs and other person-centered outcomes including psychological distress, (2) Determine participant characteristics associated with a greater treatment response using a heterogeneity of treatment effects approach, and (3) Ensure off-the-shelf intervention readiness for implementation using a mixed-methods integration of qualitative analysis of semi-structured trial participant interviews and quantitative RE-AIM implementation framework-informed trial data.
Research Team
Christopher Cox, MD, MHA, MPH
Principal Investigator
Duke
Eligibility Criteria
This trial is for older adults with critical illnesses in ICUs and their caregivers. Participants must have high levels of unmet palliative care needs. The study excludes those who don't meet the specific inclusion criteria set by the researchers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the ICUconnect app for palliative care needs assessment and communication over a 7- to 10-day period
Follow-up
Participants are monitored for outcomes such as anxiety, depression, and PTSD symptoms
Treatment Details
Interventions
- ICUconnect
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator